A study by clinical scientists at the University of Manchester in the United Kingdom has shown that schizophrenia may – in some part – be caused by disordered functioning of the immune system.
The first ever clinical trial in schizophrenia of the powerful immune suppressant drug, methotrexate, produced what the team described as “promising” effects on what are known as positive symptoms, such as hearing voices.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
